We are live on ! Find out more
JSPRW icon

Japer Therapeutics Warrants

18 hedge funds and large institutions have $1.86M invested in Japer Therapeutics Warrants in 2020 Q1 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
+18
Holders Change %
% of All Funds
0.4%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

JSPRW Hedge Fund Activity: Q1 2020 in Review

18 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Japer Therapeutics Warrants (JSPRW) for Q1 2020, worth a combined $1.86M.

Buyers outnumbered sellers: 18 funds opened new JSPRW positions and 0 closed out — a net gain of 18 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Owl Creek Asset Management, opening a new position worth an estimated $535K.

  • 18 institutional investors held Japer Therapeutics Warrants (JSPRW) as of Q1 2020, up from 0 in Q4 2019.
  • Funds reported $1.86M of Japer Therapeutics Warrants stock for Q1 2020.
  • 18 funds opened new Japer Therapeutics Warrants positions in Q1 2020 and 0 closed out, a net change of +18 holders.
  • The largest Japer Therapeutics Warrants buyer in Q1 2020 was Owl Creek Asset Management, an estimated $535K added.

Based on aggregated 13F filings for Q1 2020.